Extensive evidence for aberrant B cell hypomethylation in relapsing-remitting multiple sclerosis

被引：0
|
作者：
Ewing, E. [1 ]
Al Nimer, F. [1 ]
Fernandes, S. J. [1 ,2 ]
Kular, L. [1 ]
Stridh, P. [1 ]
Noori, P. [2 ,3 ]
Gomez-Cabrero, D. [2 ,3 ,4 ]
Tegner, J. [2 ,3 ]
Khademi, M. [1 ]
Olsson, T. [1 ]
Piehl, F. [1 ]
Jagodic, M. [1 ]
机构：
[1] Karolinska Inst, Clin Neurosci, Stockholm, Sweden
[2] Karolinska Inst, Computat Med, Stockholm, Sweden
[3] King Abdullah Univ Sci Technol, Biol Environm Sci Engn Div, Thuwal, Saudi Arabia
[4] Univ Publ Navarra, Navarrabiomed, Pamplona, Spain
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P139
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [21] Cognitive trajectories in relapsing-remitting multiple sclerosis: Evidence of multiple evolutionary trends
    London, Frederic
    De Haan, Alice
    Benyahia, Zohra
    Landenne, Gaetane
    Duprez, Thierry
    van Pesch, Vincent
    El Sankari, Souraya
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 77
  • [22] The B1-cell subpopulation is diminished in patients with relapsing-remitting multiple sclerosis
    Torring, Caroline
    Petersen, Charlotte Christie
    Bjerg, Lasse
    Kofod-Olsen, Emil
    Petersen, Thor
    Hollsberg, Per
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 262 (1-2) : 92 - 99
  • [23] Metabolomic profiling in relapsing-remitting multiple sclerosis
    Patel, Y.
    Vingara, L.
    Li, Y.
    Yu, H. J.
    Wagshul, M.
    Pelczer, I.
    Christodoulou, C.
    Melville, P.
    Maletic-Savatic, M.
    Krupp, L.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S80 - S80
  • [24] Cladribine TabletsIn Relapsing-Remitting Multiple Sclerosis
    Victoria J. Muir
    Greg L. Plosker
    CNS Drugs, 2011, 25 : 239 - 249
  • [25] Evidence of subtle hippocampal dysfunction is detectable in relapsing-remitting multiple sclerosis
    Kern, Kyle C.
    Bamberg, Allison
    Montag, Michael
    Giesser, Barbara S.
    Sicotte, Nancy L.
    MULTIPLE SCLEROSIS, 2009, 15 (11): : 1407 - 1408
  • [26] Immunomonitoring measures in relapsing-remitting multiple sclerosis
    Matsui, M
    Araya, S
    Wang, HY
    Matsushima, K
    Saida, T
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 148 (1-2) : 192 - 199
  • [27] Oral fumarate for relapsing-remitting multiple sclerosis
    Sorensen, Per Soelberg
    Sellebjerg, Finn
    LANCET, 2008, 372 (9648): : 1447 - 1448
  • [28] Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis
    M. C. Buscarinu
    S. Romano
    R. Mechelli
    R. Pizzolato Umeton
    M. Ferraldeschi
    A. Fornasiero
    R. Reniè
    B. Cerasoli
    E. Morena
    C. Romano
    N. D. Loizzo
    R. Umeton
    M. Salvetti
    G. Ristori
    Neurotherapeutics, 2018, 15 : 68 - 74
  • [29] Ibudilast in relapsing-remitting multiple sclerosis A neuroprotectant?
    Barkhof, F.
    Hulst, H. E.
    Drulovic, J.
    Uitdehaag, B. M. J.
    Matsuda, K.
    Landin, R.
    NEUROLOGY, 2010, 74 (13) : 1033 - 1040
  • [30] Quality of life in relapsing-remitting multiple sclerosis
    Dayapoglu, Nuray
    Tan, Mehtap
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2011, 27 (01) : 133 - 137
12345